Literature DB >> 12441897

Crohn disease in patients with familial Mediterranean fever.

Herma H Fidder1, Yehuda Chowers, Merav Lidar, Matan Sternberg, Pnina Langevitz, Avi Livneh.   

Abstract

Crohn disease and familial Mediterranean fever (FMF) are inflammatory diseases characterized by abdominal pain and fever. The concurrence of the 2 diseases (FMF-CD) may pose a challenge to diagnosis and treatment. We undertook the present study to determine the prevalence of Crohn disease in FMF and to characterize FMF-CD patients clinically and genetically. Using a computerized search, the patients of our FMF clinic were screened for a concomitant diagnosis of Crohn disease. Patients and their medical records were thoroughly examined, and their DNA was genotyped for mutations in the MEFV gene. Control groups of ethnically and sex-matched patients suffering from each of the diseases alone, either Crohn disease or FMF, were used for comparison. We identified 7 patients with concomitant Crohn disease and FMF, which is more than the expected prevalence in the general population (p = 0.03). Crohn disease presented at a significantly later age in the FMF-CD group (40.6 +/- 10.0 yr versus 26.2 +/- 11.4 yr; p < 0.004). Disease severity and other characteristics of Crohn disease were comparable to the Crohn disease control group. Contrary to the FMF control group patients, FMF in FMF-CD patients was characterized by a higher attack frequency (p < 0.05) and increased prevalence of amyloidosis (p < 0.02). The overall severity score was similar in both groups. In conclusion, Crohn disease appears to be more prevalent in FMF and presents later than in patients without FMF. FMF in this group of patients shows a higher attack frequency and is more often complicated by amyloidosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441897     DOI: 10.1097/00005792-200211000-00001

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  17 in total

1.  The role of MEFV mutations in the concurrent disorders observed in patients with familial Mediterranean fever.

Authors:  Sabri Güncan; N Şule Y Bilge; Döndü Üsküdar Cansu; Timuçin Kaşifoğlu; Cengiz Korkmaz
Journal:  Eur J Rheumatol       Date:  2016-09-01

2.  MEFV gene mutations and its impact on the clinical course in ulcerative colitis patients.

Authors:  Beytullah Yıldırım; Candan Tuncer; Derya Kan; Bilge Tunc; Mehmet Derya Demirag; E Ferda Percın; Seminur Haznedaroglu; Hakan Alagozlu
Journal:  Rheumatol Int       Date:  2010-03-12       Impact factor: 2.631

3.  The association of inflammatory bowel disease and Mediterranean fever gene (MEFV) mutations in Turkish children.

Authors:  Nuray Uslu; Aysel Yüce; Hülya Demir; Inci N Saltik-Temizel; Yusuf Usta; Engin Yilmaz; Nesrin Beşbaş; Figen Gürakan; Hasan Ozen; Seza Ozen
Journal:  Dig Dis Sci       Date:  2010-03-21       Impact factor: 3.199

4.  Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect?

Authors:  Stavros Giaglis; Konstantinos Mimidis; Vassilios Papadopoulos; Konstantinos Thomopoulos; Prodromos Sidiropoulos; Stavros Rafail; Vassiliki Nikolopoulou; Eleni Fragouli; Georgios Kartalis; Athanasios Tzioufas; Dimitrios Boumpas; Konstantinos Ritis
Journal:  Dig Dis Sci       Date:  2006-04       Impact factor: 3.199

5.  Frequency of functional gastrointestinal disorders in children with familial Mediterranean fever.

Authors:  Rabia Miray Kisla Ekinci; Sibel Balcı; Eray Akay; Gokhan Tumgor; Dilek Dogruel; Derya Ufuk Altintas; Mustafa Yilmaz
Journal:  Clin Rheumatol       Date:  2019-01-31       Impact factor: 2.980

6.  A novel mutation of the familial Mediterranean fever gene in a Greek family related to a non-classical, variably expressed FMF phenotype.

Authors:  Dimitrios Zonios; Clio P Mavragani; Stavros Giaglis; Konstatinos Ritis
Journal:  Rheumatol Int       Date:  2007-06-27       Impact factor: 2.631

7.  An infant with severe refractory Crohn's disease and homozygous MEFV mutation who dramatically responded to colchicine.

Authors:  Zarife Kuloğlu; Aydan Kansu; Gonca Ustündağ; Z Birsin Özçakar; Arzu Ensari; Mesiha Ekim
Journal:  Rheumatol Int       Date:  2010-01-05       Impact factor: 2.631

8.  The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy.

Authors:  Sinan Sari; Odul Egritas; Buket Dalgic
Journal:  Eur J Pediatr       Date:  2007-05-23       Impact factor: 3.183

9.  The Influence of Concomitant Disorders on Disease Severity of Familial Mediterranean Fever in Children.

Authors:  Rabia Miray Kişla Ekinci; Sibel Balci; Derya Ufuk Altintaş; Mustafa Yilmaz
Journal:  Arch Rheumatol       Date:  2017-10-30       Impact factor: 1.472

10.  Genetic variation in the familial Mediterranean fever gene (MEFV) and risk for Crohn's disease and ulcerative colitis.

Authors:  Alexandra-Chloé Villani; Mathieu Lemire; Edouard Louis; Mark S Silverberg; Catherine Collette; Geneviève Fortin; Elaine R Nimmo; Yannick Renaud; Sébastien Brunet; Cécile Libioulle; Jacques Belaiche; Alain Bitton; Daniel Gaudet; Albert Cohen; Diane Langelier; John D Rioux; Ian D R Arnott; Gary E Wild; Paul Rutgeerts; Jack Satsangi; Séverine Vermeire; Thomas J Hudson; Denis Franchimont
Journal:  PLoS One       Date:  2009-09-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.